| Loss per common share |
Loss per common share
All shares issuable for both periods were anti-dilutive because of the reported net loss. Basic and diluted loss per share for the three months ended June 30, 2016 and 2015, and six months ended June 30, 2016 and 2015, respectively, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, |
|
Six months ended June 30, |
|
|
2016 |
|
2015 |
|
2016 |
|
2015 |
Net loss attributable to stockholders |
|
$ |
(415,539 |
) |
|
$ |
(362,839 |
) |
|
$ |
(1,308,707 |
) |
|
$ |
(980,303 |
) |
Weighted average shares outstanding - Basic and diluted |
|
19,088,828 |
|
|
16,338,909 |
|
|
18,783,909 |
|
|
16,282,027 |
|
Basic and diluted loss per share |
|
$ |
(0.02 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.07 |
) |
|
$ |
(0.06 |
) |
Anti-dilutive shares underlying stock options outstanding |
|
1,196,776 |
|
|
1,186,325 |
|
|
1,196,776 |
|
|
1,186,325 |
|
Anti-dilutive convertible debentures |
|
889,830 |
|
|
555,556 |
|
|
889,830 |
|
|
555,556 |
|
Anti-dilutive warrants outstanding |
|
1,150,000 |
|
|
— |
|
|
1,150,000 |
|
|
— |
|
|